AGNES B FOGO

Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology NASHVILLE, TN NPI 1720186679

General Payments — all program years on this page

$215,756.22

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 74
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $28,096.02 across 27 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $24,440.008
Travel and Lodging $2,812.409
Food and Beverage $843.6210

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $49,250.7817
2019 $26,763.718
2020 $38,605.006
2021 $53,910.0010
2022 $19,055.725
2023 $74.991
2024 $28,096.0227

Records — PY2024 (27)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086932675 Novartis Pharmaceuticals Corporation $414.89 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1086932679 Novartis Pharmaceuticals Corporation $140.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086932683 Novartis Pharmaceuticals Corporation $7,600.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086932685 Novartis Pharmaceuticals Corporation $209.97 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086932691 Novartis Pharmaceuticals Corporation $215.76 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1086932693 Novartis Pharmaceuticals Corporation $551.48 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1086932699 Novartis Pharmaceuticals Corporation $2,800.00 06/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096553654 Novo Nordisk Health Care AG $44.52 10/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116194167 GlaxoSmithKline, LLC. $325.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118836611 Otsuka Pharmaceutical Development & Commercialization, Inc. $232.08 03/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118836613 Otsuka Pharmaceutical Development & Commercialization, Inc. $489.40 03/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118836615 Otsuka Pharmaceutical Development & Commercialization, Inc. $318.40 03/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118836617 Otsuka Pharmaceutical Development & Commercialization, Inc. $147.56 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118836619 Otsuka Pharmaceutical Development & Commercialization, Inc. $318.40 03/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118836621 Otsuka Pharmaceutical Development & Commercialization, Inc. $50.00 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118836623 Otsuka Pharmaceutical Development & Commercialization, Inc. $50.00 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118836625 Otsuka Pharmaceutical Development & Commercialization, Inc. $20.14 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118836627 Otsuka Pharmaceutical Development & Commercialization, Inc. $9,715.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118836629 Otsuka Pharmaceutical Development & Commercialization, Inc. $36.45 04/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118836631 Otsuka Pharmaceutical Development & Commercialization, Inc. $9.76 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141513265 CALLIDITAS THERAPEUTICS US INC. $65.73 04/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141525720 CALLIDITAS THERAPEUTICS US INC. $1,000.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141525722 CALLIDITAS THERAPEUTICS US INC. $1,000.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141525724 CALLIDITAS THERAPEUTICS US INC. $500.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141528041 CALLIDITAS THERAPEUTICS US INC. $235.54 11/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920072 Travere Therapeutics, Inc. $105.94 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920076 Travere Therapeutics, Inc. $1,500.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.